List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 499 studies with search of: "Hematinics"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting A Clinical Trial of IntensiVE Dialysis
Conditions: Renal Replacement Therapy;   Renal Dialysis;   End Stage Kidney Disease;   End Stage Renal Disease;   Uremia
Intervention: Procedure: haemodialysis
2 Completed Effect of Iron Therapy as an Adjunct to Epoetin Alfa in the Anemia of Cancer Chemotherapy
Condition: Anemia
Intervention: Drug: Sodium ferric gluconate, ferrous sulfate, standard of care
3 Terminated A Study of Subcutaneous Mircera, Versus no Erythropoiesis-Stimulating Agent (ESA) Therapy, in the Treatment of Anemia in Patients With Chronic Kidney Disease After Kidney Transplant
Condition: Anemia
Interventions: Drug: methoxy polyethylene glycol-epoetin beta [Mircera];   Drug: Supportive treatment
4 Enrolling by invitation A Prospective, Immunogenicity Surveillance Registry of Erythropoiesis Stimulating Agent (ESA) With Subcutaneous Exposure in Thailand
Condition: Erythropoietin
Intervention:
5 Not yet recruiting The Clinical Evaluation of the Dose of Erythropoietins Trial
Condition: Kidney Failure, Chronic
Interventions: Drug: Erythropoiesis Stimulating Agents (ESAs): epoetin alfa, beta or any other epoetin in equivalent dose.;   Drug: Erythropoiesis Stimulating Agents (ESAs): epoetin alfa, beta or any other epoetin in equivalent dose.
6 Completed Safety, PD & PK of Multiple Doses of Hematide™ Injections for Anemia in Chronic Kidney Disease Patients
Conditions: Anemia;   Chronic Kidney Disease
Intervention: Drug: Hematide™
7 Active, not recruiting Safety and Efficacy of Hematide™ for the Correction of Anemia in Patients With Chronic Renal Failure (PEARL 2)
Conditions: Chronic Renal Failure;   Anemia
Interventions: Drug: Hematide™;   Drug: Darbepoetin Alfa
8 Recruiting Safety Study of Hematide to Correct Anemia in Hemodialysis Patients
Conditions: Anemia;   Chronic Renal Failure
Interventions: Drug: Hematide;   Drug: Hematide;   Drug: Epoetin Alfa
9 Completed Audit of the Effect of Changing From IV to SC Administration of ESA's in Haemodialysis Patients
Conditions: Kidney Failure, Chronic;   Anemia
Intervention: Drug: Eprex; Neorecormon; Aranesp
10 Completed Epoetin Dosing Regimens in Haemodialysis
Conditions: Hemodialyzed Patients;   Epoetin Treatment
Intervention: Drug: NeoRecormon SC once-weekly versus once-every-other-week
11 Active, not recruiting Safety & Efficacy of Hematide™ for the Correction of Anemia in Patients With Chronic Renal Failure
Conditions: Chronic Renal Failure;   Anemia
Interventions: Drug: Hematide™;   Drug: Hematide™;   Drug: Darbepoetin Alfa
12 Active, not recruiting Iron Sucrose in Non-Dialysis Dependent (NDD-CKD) Pediatric Patients
Condition: Anemia
Intervention: Drug: Venofer
13 Completed Safety of Single Doses of Hematide in Patients With Chronic Kidney Disease
Condition: Kidney Diseases
Interventions: Drug: Hematide™;   Drug: Placebo
14 Completed Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
Conditions: Breast Cancer;   Cancer-Related Problem/Condition;   Chronic Myeloproliferative Disorders;   Leukemia;   Lung Cancer;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Precancerous/Nonmalignant Condition;   Small Intestine Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Biological: epoetin alfa;   Procedure: quality-of-life assessment
15 Completed Study of the Efficacy and Safety of Epoetin Alfa Administered Weekly in Patients With Gastric or Rectal Cancers Undergoing a Treatment Plan of Preoperative Chemotherapy and Radiation Therapy, Followed by Surgery
Conditions: Rectal Neoplasms;   Stomach Neoplasms
Intervention: Drug: epoetin alfa
16 Completed BVAIT: B-Vitamin Atherosclerosis Intervention Trial
Condition: Atherosclerosis
Interventions: Drug: folic acid;   Drug: vitamin B12;   Drug: vitamin B6
17 Recruiting PROTECT: Prospective Trial on Erythropoietin in Clinical Transplantation
Condition: Patients Receiving a Kidney From a Non-Heart-Beating Donor
Intervention: Drug: epoetin beta
18 Completed Early and Standard Intervention With 120,000 Units of PROCRIT (Epoetin Alfa) Every Three Weeks in Patients Receiving Chemotherapy
Condition: Anemia
Intervention: Drug: PROCRIT (Epoetin alfa)
19 Recruiting Multivitamin Comparison in Kidney Transplant Recipients
Condition: Kidney Transplantation
Intervention: Drug: Folic Acid
20 Completed EPO-BUL-01 - Study of the Optimization of Anemia Management of EPREX (Epoetin Alfa) in Predialysis Patients With Chronic Renal Failure
Condition: Chronic Renal Failure
Intervention: Drug: Epoetin alfa

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services